(Q28138899)

Action of the Caenorhabditis elegans GATA factor END-1 in Xenopus suggests that similar mechanisms initiate endoderm development in ecdysozoa and vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

SUMO-1: wrestling with a new ubiquitin-related modifier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Ubch9 conjugates SUMO but not ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MAT alpha 2 repressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

A new protease required for cell-cycle progression in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Differential regulation of sentrinized proteins by a novel sentrin-specific protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Ubiquitin-dependent protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

DNA topoisomerase poisons as antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Identification of three major sentrinization sites in PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

SUMO-1 modification activates the transcriptional response of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001831200

21 January 2018

Identifiers

DOI

10.1074/JBC.M001831200

1 reference

Consolidated OpenCitations Corpus – April 2017

4804656

4804656

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference